Wolfgang Jahnke
Novartis (Switzerland)(CH)Novartis (China)(CN)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Chronic Myeloid Leukemia Treatments, Genetics, Bioinformatics, and Biomedical Research, Protein Structure and Dynamics, Click Chemistry and Applications
Most-Cited Works
- → Twenty years on: the impact of fragments on drug discovery(2016)963 cited
- → Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors(2010)596 cited
- → The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1(2017)581 cited
- → A simple protocol for amino acid type selective isotope labeling in insect cells with improved yields and high reproducibility(2011)476 cited
- → Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1(2018)436 cited
- → Perspectives on NMR in drug discovery: a technique comes of age(2008)409 cited